Unsupervised Flow Cytometry Analysis Allows for an Accurate Identification of Minimal Residual Disease Assessment in Acute Myeloid Leukemia

SIMPLE SUMMARY: In acute myeloid leukemia (AML), minimal/measurable residual disease (MRD) can be assessed based on molecular markers or immunophenotypic features evaluated at diagnosis, through multiparameter flow cytometry (MFC) for the latter. New artificial intelligence tools allow to perform un...

Descripción completa

Detalles Bibliográficos
Autores principales: Vial, Jean Philippe, Lechevalier, Nicolas, Lacombe, Francis, Dumas, Pierre-Yves, Bidet, Audrey, Leguay, Thibaut, Vergez, François, Pigneux, Arnaud, Béné, Marie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914957/
https://www.ncbi.nlm.nih.gov/pubmed/33562525
http://dx.doi.org/10.3390/cancers13040629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914957/
https://www.ncbi.nlm.nih.gov/pubmed/33562525
http://dx.doi.org/10.3390/cancers13040629

Ejemplares similares